Ohio Third Frontier Commission bolsters Case Western Reserve University startup funding
Case Western Reserve’s work to bring university breakthroughs to the public received a recent boost from the Ohio...
Technology Transfer Office
Case Western Reserve and Atelerix Life Sciences Inc. sign option license to develop new therapeutic approach to opioid crisis
Novel small molecule technology reverses life-threatening opioid-induced respiratory depression without diminishing pain relief Case Western Reserve University and...
A team effort
Journey to multi-million dollar Amgen acquisition required curiosity, collaboration and commercial expertise Twenty years after starting a cancer...
Case Western Reserve University biotech startup Rodeo Therapeutics Corp. sold to Amgen Inc.
Deal worth $55M, plus potential milestones of up to $666M Rodeo Therapeutics Corp., a drug-development startup founded by...
Beyond Silicon Valley: “Anchor Institutions” with Walid Jalabi and Lana Franks
Join the Veale Institute for Entrepreneurship via Zoom Thursday, Oct. 1, at 10 a.m. ET for “Beyond Silicon...
Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases
Agreement with CWRU Technology Transfer Office and Dartmouth College Mosaic ImmunoEngineering Inc., a private biotechnology company based in...
Luminary Therapeutics and Case Western Reserve University enter formal collaboration for development of BAFF CAR
Luminary Therapeutics (Luminary Tx) and Case Western Reserve University have entered into a formal collaboration agreement that includes...
Adjustable walker from Case Western Reserve and Louis Stokes VA moves closer to market
Product allows users to navigate uneven surfaces, offering promise of greater independence An adjustable walker that allows users...
Case Western Reserve completes license option with “spinout” company Edifice Analytics Inc.
Technology developed at CWRU allows a building’s energy use to be audited remotely, saving time and money ...
Haima Therapeutics licenses synthetic platelet technology from Case Western Reserve University for hemostatic therapy
Haima Therapeutics has executed an exclusive license agreement with Case Western Reserve University to research, develop and market artificial...